Listed

InterDigital, Inc.: Form 10-Q for the period ended Sep 30, 2020

Filed with the SEC on Nov 5, 2020 and accepted by EDGAR at Nov 5, 2020, 08:34 ET.

Share

Management's discussion and analysis

As filed, 35,009 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

OVERVIEW

The following discussion should be read in conjunction with the unaudited, condensed consolidated financial statements and notes thereto contained in Part I, Item 1 of this Quarterly Report on Form 10-Q, in addition to our 2019 Form 10-K, other reports filed with the SEC and the Statement Pursuant to the Private Securities Litigation Reform Act of 1995 — Forward-Looking Statements below.

Throughout the following discussion and elsewhere in this Form 10-Q, we refer to “recurring revenues” and “non-recurring revenues.” Recurring revenues are comprised of “current patent royalties” and “current technology solutions revenue.” Non-recurring revenues are comprised of “non-current patent royalties,” which primarily include past patent royalties and royalties from static agreements, as well as “patent sales.”

Throughout the following discussion and elsewhere in this Form 10-Q, we refer to the “Technicolor Acquisitions” which is the combined Technicolor Patent Acquisition, which closed in July 2018 and was integrated throughout 2019, and the R&I Acquisition, which closed May 2019 together.

Recurring Revenue

Third quarter 2020 recurring revenue was $87.0 million, compared to recurring revenue of $72.1 million in third quarter 2019, a 21% year-over-year increase. The increase primarily driven by eight new patent license agreements signed over the last twelve months, including Huawei and ZTE. Refer to "Results of Operations --Third Quarter 2020 Compared to Third Quarter 2019" for further discussion of our 2020 revenue.

Impact of COVID-19 Pandemic

In March 2020, the World Health Organization categorized the novel coronavirus ("COVID-19") as a pandemic, and it continues to significantly impact the United States and the rest of the world. Though the COVID-19 pandemic and the measures taken to reduce its transmission, such as the imposition of social distancing and orders to work-from-home and shelter-in-place, have altered our business environment and overall working conditions, we continue to believe that our strategic strengths, including talent, our strong balance sheet, stable revenue base, and the strength of our patent portfolio, will allow us to weather a rapidly changing marketplace.

While the environment in which we conduct our business and our overall working conditions have changed as a result of the COVID-19 pandemic, we experienced a limited impact on our operations and financial position during first nine months of 2020. As discussed in our 2019 Form 10-K, fixed-fee royalties accounted for nearly 90% of our revenues in 2019. These fixed-fee revenues are not directly affected by our related licensees’ success in the market or the general economic climate. To that end, in first nine months of 2020, we did not experience a significant impact on our revenue due to COVID-19. Meanwhile, we have taken steps to protect the health and safety of our employees and their families, with our entire worldwide workforce continuing to work remotely. Despite these remote working conditions, our business activities have continued to operate with minimal interruption, and we expect them to continue to operate efficiently. Nearly all work-related travel continues to remain suspended, and we have conducted our licensing negotiations, investor presentations and participation in standards organizations and industry events virtually. Our financial position remains strong, we have sufficient access to capital if needed, and we remain committed to our efforts around cost discipline.

Despite our success thus far in navigating the challenging environment that COVID-19 has presented, as more fully discussed in Part II, Item 1A "Risk Factors" in this Quarterly Report on Form 10-Q, the extent to which COVID-19 will adversely impact our business, financial condition and results of operations is dependent upon numerous factors resulting therefrom, many of which are highly uncertain, rapidly changing and uncontrollable. However, with a strong balance sheet and the vast majority of our current revenue coming from fixed price agreements, we believe that we are well-positioned to continue to overcome and adapt to the challenges that we have been presented with thus far.

Comparability of Financial Results

When comparing third quarter 2020 financial results against other periods, the following items should be taken into consideration:

  • the third quarter 2020 tax provision includes discrete benefits of $18.5 million, which primarily relates to the expected amendment of a prior year tax return to utilize a tax asset generated in the current year, as well as the reversal of a tax reserve.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Our significant accounting policies are described in Note 2, "Summary of Significant Accounting Policies and New Accounting Guidance", in the Notes to Consolidated Financial Statements included in our 2019 Form 10-K. A discussion of our critical accounting policies, and the estimates related to them, are included in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our 2019 Form 10-K. There have been no material changes to our existing critical accounting policies from the disclosures included in our 2019 Form 10-K. In addition, we have analyzed the impact of COVID-19 on our financial statements as of September 30, 2020, and we have determined that the changes to our significant judgments and estimates did not have a material impact on our financial statements. Refer to Note 1, “Basis of Presentation,” in the Notes to Condensed Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q for updates related to new accounting pronouncements and changes in accounting policies.

FINANCIAL POSITION, LIQUIDITY AND CAPITAL RESOURCES

Our primary sources of liquidity are cash, cash equivalents and short-term investments, as well as cash generated from operations. We believe we have the ability to obtain additional liquidity through debt and equity financings. Based on our past performance and current expectations, we believe our available sources of funds, including cash, cash equivalents and short-term investments and cash generated from our operations, will be sufficient to finance our operations, capital requirements, debt obligations, existing stock repurchase program and dividend program for the next twelve months.

Cash, cash equivalents, restricted cash and short-term investments

As of September 30, 2020 and December 31, 2019, we had the following amounts of cash, cash equivalents, restricted cash and short-term investments (in thousands):

September 30, 2020 December 31, 2019 Increase / (Decrease)
Cash and cash equivalents $746,561 $745,491 $1,070
Restricted cash included within prepaid and other current assets 4,401 10,526 (6,125)
Restricted cash included within other non-current assets 1,081 1,081 —
Short-term investments 172,822 179,204 (6,382)
Total cash, cash equivalents, restricted cash and short-term investments $924,865 $936,302 $(11,437)

The net decrease in cash, cash equivalents, restricted cash and short-term investments was attributable to cash used in financing activities of $127.3 million, primarily related to the repayment of our 2020 Notes and dividend payments, and by cash used in investing activities of $29.3 million, excluding sales and purchases of short-term investments. These decreases were partially offset by cash provided by operating activities of $144.2 million. Refer to the sections below for further discussion of these items.

Cash flows from operations

We generated the following cash flows in our operating activities in first nine months 2020 and 2019 (in thousands):

Nine months ended September 30, 2020 2019 Increase / (Decrease)
Net cash provided by operating activities $144,212 $71,976 $72,236

Our cash flows provided by operating activities are principally derived from cash receipts from patent license and technology solutions agreements, offset by cash operating expenses and income tax payments. The $72.2 million change in net cash provided by operating activities was primarily driven by higher cash receipts primarily related to new patent license agreements signed over the last twelve months, as well as the timing of cash receipts related to patent license agreements. The table below sets forth the significant items comprising our cash flows provided by operating activities during the nine months ended September 30, 2020 and 2019 (in thousands):

Cash Receipts: Nine months ended September 30, 2020 2019 Increase / (Decrease)
Patent royalties $303,918 $217,284 $86,634
Technology solutions 4,678 5,765 (1,087)
Total cash receipts 308,596 223,049 85,547
Cash Outflows:
Cash operating expenses a 147,310 140,590 6,720
Income taxes paid b 18,211 16,483 1,728
Total cash outflows 165,521 157,073 8,448
Other working capital adjustments 1,137 6,000 (4,863)
Cash flows provided by operating activities $144,212 $71,976 $72,236

(a) Cash operating expenses include operating expenses less depreciation of fixed assets, amortization of patents, non-cash compensation and non-cash changes in fair value.

(b) Income taxes paid include foreign withholding taxes.

Cash flows from investing and financing activities

Net cash used in investing activities in first nine months 2020 was $22.0 million, a ($266.2 million) change from $244.2 million net cash provided by investing activities in first nine months 2019. During first nine months 2020, we sold $7.4 million of short-term marketable securities, net of purchases. During first nine months 2019, we sold $263.4 million of short-term marketable securities, net of purchases.

Net cash used in financing activities for first nine months 2020 was $127.3 million, an increase of $68.6 million from net cash used in financing activities of $58.7 million for first nine months 2019. This change was primarily attributable to a net proceeds of $140.2 million from the debt refinancing (net of related expenses) in second quarter 2019 and $10.3 million proceeds from noncontrolling interests received in first nine months 2019. These first nine months 2019 activities were partially offset by a reduction of $171.3 million in share repurchases, as well as $94.9 million payment on long-term debt related to the repayment of our 2020 Notes during the first nine months 2020.

Other

Our combined short-term and long-term deferred revenue balance as of September 30, 2020 was approximately $356.7 million, a net increase of $86.4 million from December 31, 2019. This increase in deferred revenue was primarily attributable to timing of cash receipts from our dynamic fixed-fee royalty agreements, including the second quarter 2020 patent license agreement with Huawei.

Based on current license agreements, we expect the amortization of dynamic fixed-fee royalty payments to reduce the September 30, 2020 deferred revenue balance of $356.7 million by $248.1 million over the next twelve months.

Convertible Notes

See Note 8, “Long-Term Debt” to the Notes to Condensed Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q for definitions of capitalized terms below.

Our 2024 Notes, which for purposes of this discussion are also referred to as the "Convertible Notes", are included in the dilutive earnings per share calculation using the treasury stock method. Under the treasury stock method, we must calculate the number of shares of common stock issuable under the terms of the Convertible Notes based on the average market price of our common stock during the applicable reporting period and include that number in the total diluted shares figure for the period. At the time we issued the Convertible Notes, we entered into the 2024 Call Spread Transactions that together were designed to have the economic effect of reducing the net number of shares that will be issued in the event of conversion of the Convertible Notes by, in effect, increasing the conversion price of the Convertible Notes from our economic standpoint. However, under GAAP, since the impact of the 2024 Note Hedge Transactions is anti-dilutive, we exclude from the calculation of fully diluted shares the number of shares of our common stock that we would receive from the counterparties to these agreements upon settlement.

During periods in which the average market price of our common stock is above the applicable conversion price of the Convertible Notes ($81.29 per share for the 2024 Notes as of September 30, 2020) or above the strike price of the warrants ($109.43 per share for the 2024 Warrant Transactions as of September 30, 2020), the impact of conversion or exercise, as applicable, would be dilutive and such dilutive effect is reflected in diluted earnings per share. As a result, in periods where the average market price of our common stock is above the conversion price or strike price, as applicable, under the treasury stock method, we calculate the number of shares issuable under the terms of the Convertible Notes and the warrants based on the average market price of the stock during the period, and includes that number in the total diluted shares outstanding for the period.

Under the treasury stock method, changes in the price per share of our common stock can have a significant impact on the number of shares that we must include in the fully diluted earnings per share calculation. As described in Note 8, "Long-Term Debt," it is our current intent and policy to settle all conversions of the Convertible Notes through a combination settlement of cash and shares of common stock, with a specified dollar amount of $1,000 per $1,000 principal amount of the Convertible Notes and any remaining amounts in shares ("net share settlement"). Assuming net share settlement upon conversion, the following table illustrates how, based on the $400.0 million aggregate principal amount of the 2024 Notes as of September 30, 2020, and the approximately 4.9 million warrants related to the 2024 Notes outstanding as of the same date, changes in our stock price would affect (i) the number of shares issuable upon conversion of the Convertible Notes, (ii) the number of shares issuable upon exercise of the warrants subject to the 2024 Warrant Transactions, (iii) the number of additional shares deemed outstanding with respect to the Convertible Notes, after applying the treasury stock method, for purposes of calculating diluted earnings per share ("Total Treasury Stock Method Incremental Shares"), (iv) the number of shares of common stock deliverable to us upon settlement of the 2024 Note Hedge Transactions and (v) the number of shares issuable upon concurrent conversion of the Convertible Notes, exercise of the warrants subject to the 2024 Warrant Transactions, and settlement of the 2024 Note Hedge Transactions:

2024 Notes

(Shares in thousands)

Market Price Per Share Shares Issuable Upon Conversion of the 2024 Notes Shares Issuable Upon Exercise of the 2024 Warrant Transactions Total Treasury Stock Method Incremental Shares Shares Deliverable to InterDigital upon Settlement of the 2024 Note Hedge Transactions Incremental Shares Issuable (a)
$85 215 — 215 (215) —
$90 476 — 476 (476) —
$95 710 — 710 (710) —
$100 921 — 921 (921) —
$105 1,111 — 1,111 (1,111) —
$110 1,284 25 1,309 (1,284) 25
$115 1,442 238 1,680 (1,442) 238
$120 1,587 433 2,020 (1,587) 433
$125 1,721 613 2,334 (1,721) 613
$130 1,844 779 2,623 (1,844) 779

26

(a) Represents incremental shares issuable upon concurrent conversion of convertible notes, exercise of warrants and settlement of the hedge agreements.

RESULTS OF OPERATIONS

Third Quarter 2020 Compared to Third Quarter 2019

Revenues

The following table compares third quarter 2020 revenues to third quarter 2019 revenues (in thousands):

Three months ended September 30, 2020 2019 Total Increase/(Decrease)
Variable patent royalty revenue $7,377 $4,683 $2,694 58%
Fixed-fee royalty revenue 77,338 63,736 13,602 21%
Current patent royalties a 84,715 68,419 16,296 24%
Non-current patent royalties b 507 (370) 877 237%
Total patent royalties 85,222 68,049 17,173 25%
Current technology solutions revenue a 2,271 3,724 (1,453) (39)%
Patent sales b — 750 (750) (100)%
Total revenue $87,493 $72,523 $14,970 21%

a. Recurring revenues are comprised of current patent royalties, inclusive of Dynamic Fixed-Fee Agreement royalties, and current technology solutions revenue.

b. Non-recurring revenues are comprised of non-current patent royalties, which primarily include past patent royalties and royalties from static agreements, as well as patent sales.

The $15.0 million increase in total revenue was primarily due to a $14.8 million increase in recurring revenue and a $0.9 million increase in non-current patent royalties both primarily driven by eight new patent license agreements signed over the last twelve months, including Huawei and ZTE.

In third quarter 2020 and third quarter 2019, 67% and 77% of our total revenue, respectively, was attributable to companies that individually accounted for 10% or more of our total revenue. In third quarter 2020 and third quarter 2019, the following companies accounted for 10% or more of our total revenue:

Three months ended September 30, 2020 2019
Apple 32% 39%
Samsung 22% 27%
Huawei 13% —%
LG <10% 11%

Operating Expenses

The following table summarizes the changes in operating expenses between third quarter 2020 and third quarter 2019 by category (in thousands):

Three months ended September 30, 2020 2019 Increase/(Decrease)
Patent administration and licensing $40,364 $34,772 $5,592 16%
Development 20,845 20,506 339 2%
Selling, general and administrative 10,854 13,471 (2,617) (19)%
Total operating expenses $72,063 $68,749 $3,314 5%

27

Operating expenses increased to $72.1 million in third quarter 2020 from $68.7 million in third quarter 2019. The $3.3 million increase in total operating expenses was primarily due to changes in the following items (in thousands):

Increase/(Decrease)
Revenue sharing for Madison Arrangement 1,319
Corporate initiatives 600
Patent maintenance 595
Intellectual property enforcement and non-patent litigation 386
Other 414
Total increase in operating expenses $3,314

The $3.3 million increase in operating expenses was primarily driven a $1.3 million increase related to revenue sharing from the Madison Arrangement, a $0.6 million increase from corporate initiatives for tax planning opportunities, a $0.6 million increase in patent maintenance costs attributable to patents acquired over the last twelve months and a $0.4 million increase in intellectual property enforcement costs primarily driven by the on-going Lenovo and Xiaomi litigations.

Patent Administration and Licensing Expense: The increase in patent administration and licensing expense primarily resulted from the above-noted increases related to patent maintenance and intellectual property enforcement costs. These increases were partially offset by lower one-time costs related to Technicolor Acquisitions, as well lower personnel-related costs, among other decreases.

Development Expense: Development expense were relatively flat as compared to third quarter 2019.

Selling, General and Administrative Expense: The decrease in selling, general and administrative expense was primarily due to the lower one-time costs associated with the Technicolor acquisitions as well as reduced travel due to 2020 COVID-19 travel restrictions, and lower personnel-related costs.

Non-Operating Income (Expense)

The following table compares third quarter 2020 non-operating income (expense) to third quarter 2019 non-operating income (expense) (in thousands):

Three months ended September 30, 2020 2019 Change
Interest expense $(10,365) $(10,920) $555 5%
Interest and investment income 825 3,687 (2,862) (78)%
Gain on asset acquisition — 8,515 (8,515) (100)%
Other income (expense), net 3,169 (4,399) 7,568 172%
Total non-operating income (expense) $(6,371) $(3,117) $(3,254) (104)%

The change in non-operating income (expense) between periods was primarily driven by the recognition of a gain of $8.5 million related to the sale of our Hillcrest product business in third quarter 2019. Additionally, third quarter 2019 includes a $3.3 million loss resulting from the partial impairment of one of our strategic long-term investments, which is included in the "Other income (expense), net" caption in the table above.

Income taxes

In third quarter 2020, we had an effective tax rate of (141.8)%. In third quarter 2020, the Company recorded a net discrete benefit of $18.5 million that primarily related to the expected amendment of a prior year tax return to utilize a tax asset generated in the current year, as well as the reversal of a tax reserve. This is compared to an effective tax rate of 27.1% based on the statutory federal tax rate net of discrete federal and state taxes during third quarter 2019.

On December 22, 2017, the Tax Cuts and Jobs Act of 2017 (the "Tax Reform Act") was signed into law. The Tax Reform Act imposes a 13.125% tax rate on income that qualifies as Foreign Derived Intangible Income ("FDII"). On July 9, 2020, the IRS issued final regulations for FDII. The Company is currently evaluating and will record the impact, if any, as applicable.

First Nine Months 2020 Compared to First Nine Months 2019

Revenues

The following table compares first nine months 2020 revenues to first nine months 2019 revenues (in thousands):

Nine months ended September 30, 2020 2019 Total Increase/(Decrease)
Variable patent royalty revenue $17,920 $22,557 $(4,637) (21)%
Fixed-fee royalty revenue 221,023 190,345 30,678 16%
Current patent royalties a 238,943 212,902 26,041 12%
Non-current patent royalties b 20,461 (4,908) 25,369 517%
Total patent royalties 259,404 207,994 51,410 25%
Current technology solutions revenue a 8,797 7,794 1,003 13%
Patent sales b — 975 (975) (100)%
Total revenue $268,201 $216,763 $51,438 24%

(a) Recurring revenues are comprised of current patent royalties, inclusive of Dynamic Fixed-Fee Agreement royalties, and current technology solutions revenue.

(b) Non-recurring revenues are comprised of non-current patent royalties, which primarily include past patent royalties and royalties from static agreements, as well as patent sales.

The $51.4 million increase in total revenue was primarily driven a $27.0 million increase in recurring revenue and a $25.4 million increase in non-current patent royalties both primarily driven by eight new patent license agreements signed over the last twelve months, including Huawei and ZTE. The increase in non-current patent royalties was also due to the inclusion of a $5.5 million net charge recorded as contra non-recurring revenue during nine months ended 2019 related to a restructured licensing arrangement with a long-term customer.

In first nine months 2020 and first nine months 2019, 68% and 77% of our total revenue, respectively, was attributable to companies that individually accounted for 10% or more of our total revenue. In first nine months 2020 and first nine months 2019, the following companies accounted for 10% or more of our total revenue:

Nine months ended September 30, 2020 2019
Apple 31% 39%
Samsung 22% 27%
Huawei 15% —%
LG < 10% 11%

Operating Expenses

The following table summarizes the changes in operating expenses between first nine months 2020 and first nine months 2019 by category (in thousands):

Nine months ended September 30, 2020 2019 Increase/(Decrease)
Patent administration and licensing $119,167 $108,196 $10,971 10%
Development 61,755 56,028 5,727 10%
Selling, general and administrative 35,251 40,000 (4,749) (12)%
Total operating expenses $216,173 $204,224 $11,949 6%

Operating expenses increased 6% to $216.2 million in first nine months 2020 from $204.2 million in first nine months 2019. The $11.9 million increase in total operating expenses was primarily due to changes in the following items (in thousands):

Increase/(Decrease)
Recurring operations of the Technicolor Acquisitions $11,183
One-time costs related to the Technicolor Acquisitions (5,011)
Revenue sharing for Madison Arrangement 1,958
Corporate initiatives 2,552
Intellectual property enforcement and non-patent litigation 2,536
Amortization 1,771
Performance-based incentive compensation 1,443
Personnel-related costs (4,316)
Other (167)
Total increase in operating expenses $11,949

The $11.9 million increase in operating expenses was primarily driven by the Technicolor Acquisitions, which contributed $49.2 million to our first nine months 2020 operating expenses. The $49.2 million of operating expenses is comprised of $45.4 million of recurring costs, of which $13.0 million relates to patent amortization, $1.8 million relates to transaction and integration costs and the remaining $2.0 million relates to revenue sharing from the Madison arrangement. during first nine months 2020. This compares to $41.1 million of operating expenses in first nine months 2019. First nine months 2019 was comprised of $34.3 million of recurring costs, of which $12.5 million relates to patent amortization, and the remaining $6.9 million related to transaction and integration costs.

During first nine months 2020, the Company incurred $2.6 million of additional costs attributable to corporate initiatives as part of its on-going efforts to optimize its cost structure, including the closure of our San Diego office. The $2.5 million increase in intellectual property enforcement costs was primarily driven the on-going Lenovo and Xiaomi litigations. Amortization expense increased by $1.8 million and was largely driven by patents acquired over the last twelve-months. Performance-based incentive compensation increased by $1.4 million, primarily due to increased performance accruals driven by the Huawei PLA signed in second quarter 2020. Lastly, corporate initiatives to optimize our cost structure drove a $4.3 million decrease in personnel-related costs.

Patent Administration and Licensing Expense: The increase in patent administration and licensing expense primarily resulted from the above-noted increases related to intellectual property enforcement costs and performance-based incentive compensation, as well as increased patent maintenance costs.

Development Expense: The increase in development expense primarily resulted from the above-noted increases related to the Technicolor Acquisitions. These increases were partially offset by lower personnel-related costs, primarily related to our second quarter 2019 sale of the Hillcrest product business and reductions in other non-cellular research areas.

Selling, General and Administrative Expense: The decrease in selling, general and administrative expense primarily resulted from the above-noted reduction in personnel-related costs, as well as lower one-time costs associated with the Technicolor acquisitions. These decreases were partially offset by the above-noted increases in performance-based incentive compensation and corporate initiatives.

Non-Operating Income (Expense)

The following table compares first nine months 2020 non-operating income (expense) to first nine months 2019 non-operating income (expense) (in thousands):

Nine months ended September 30, 2020 2019 Change
Interest expense $(30,881) $(30,305) $(576) (2)%
Interest and investment income 5,044 10,173 (5,129) (50)%
Gain on asset acquisition and sale of business — 22,690 (22,690) (100)%
Loss on extinguishment of long-term debt — (5,488) 5,488 (100)%
Other income (expense), net 8,762 (3,603) 12,365 343%
Total non-operating income (expense) $(17,075) $(6,533) $(10,542) (161)%

The change in non-operating income (expense) between periods was primarily driven by the recognition of an aggregate $22.7 million gain on asset acquisition and sale of business during first nine months 2019, of which $14.2 million relates to the Technicolor R&I acquisition in second quarter 2019 and $8.5 million relates to the gain on sale of our Hillcrest product business in third quarter 2019. These gains were partially offset by the recognition of a $5.5 million loss on extinguishment of debt recognized in connection with the settlement of a portion of our 2020 Notes in second quarter 2019. Additionally, first nine months 2019 includes a $3.3 million loss resulting from the partial impairment of one of our strategic long-term investments, which is included in the "Other income (expense), net" caption in the table above Comparatively, the other income (expense) first nine months 2020 includes a $5.5 million gain resulting from observable price changes in orderly transactions of one of our long-term strategic investments.

Income taxes

In first nine months 2020, we had an effective tax rate of (16.8)%. The negative effective tax rate was driven by a net discrete benefit of $18.2 million that primarily relates to the expected amendment of a prior year tax return to utilize a tax asset generated in the current year, as well as the reversal of a tax reserve. This is compared to an effective tax rate of 50.1% based on the statutory federal tax rate net of discrete federal and state taxes during first nine months 2019. During first nine months 2019, we recorded discrete expense of $3.1 million related to the R&I Acquisition, the extinguishment of long-term debt, the filing of amended federal income tax returns and the sale of our Hillcrest product business.

As noted above, on December 22, 2017, the Tax Reform Act was signed into law. The Tax Reform Act imposes a 13.125% tax rate on income that qualifies as FDII. The reduction in benefit is primarily related to the differences in our FDII deduction between the periods. The difference in the FDII deduction between the periods was driven by the timing of income between book and tax mostly related to revenue recognition. On July 9, 2020, the IRS issued final regulations for FDII. The Company is currently evaluating and will record the impact, if any, as applicable.

STATEMENT PURSUANT TO THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 — FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include certain information under the heading “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations” and other information regarding our current beliefs, plans and expectations, including without limitation the matters set forth below. Words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “forecast,” “goal,” variations of any such words or similar expressions are intended to identify such forward-looking statements. Forward-looking statements in this Quarterly Report on Form 10-Q include, without limitation, statements regarding:

  • Our expectations regarding the potential effects of new accounting standards on our financial position, results of operations or cash flows;
  • Our expectation that the amortization of dynamic fixed-fee royalty payments will reduce our September 30, 2020 deferred revenue balance over the next twelve months;
  • Our expectations with respect to revenue to be recognized based on contracts signed and committed Dynamic Fixed-Fee Agreement payments as of September 30, 2020;
  • Our expectations and estimations regarding the income tax effects, and the impact on the Company, of the Tax Reform Act, including our forecasted net benefit related to our income qualifying as FDII;
  • Our expectations with respect to anticipated tax refunds to be received from amending certain tax returns;
  • The timing, outcome and impact of, and plans, expectations and beliefs with respect to, our various litigation, arbitration, regulatory and administrative matters;
  • Our belief that we have the ability to obtain additional liquidity through debt and equity financings;
  • Our expectations with respect to the impact of the Technicolor Acquisitions on our financial statements and our business;
  • Our belief that our available sources of funds will be sufficient to finance our operations, capital requirements, debt obligations, existing stock repurchase program and dividend program for the next twelve months;
  • Our expectation that we will continue to pay dividends comparable to our quarterly $0.35 per share cash dividend in the future;
  • Our expectations regarding our customers’ ability to continue to pay fixed fee payments owed to us despite the ongoing COVID-19 pandemic; and
  • Our expectations regarding the potential effects of the ongoing COVID-19 pandemic on our financial position, results of operations and cash flows.

Forward-looking statements concerning our business, results of operations and financial condition are inherently subject to risks and uncertainties that could cause actual results, and actual events that occur, to differ materially from results contemplated by the forward-looking statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties outlined in greater detail in Part I, Item 1A of our 2019 Form 10-K and Part II, Item 1A "Risk Factors" in this Quarterly Report on Form 10-Q. We undertake no obligation to revise or update publicly any forward-looking statement for any reason, except as otherwise required by law.

Market risk

As filed, 132 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes in quantitative and qualitative market risk from the disclosures included in our 2019 Form 10-K.

Controls and procedures

As filed, 1,383 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The Company’s principal executive officer and principal financial officer, with the assistance of other members of management, have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective to ensure that the information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and to ensure that the information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934, as amended, is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. There were no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2020, that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 4,708 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Reference is made to Part I, Item 1A, “Risk Factors” included in our 2019 Form 10-K for information concerning risk factors, which should be read in conjunction with the factors set forth in the Statement Pursuant to the Private Securities Litigation Reform Act of 1995 -- Forward-Looking Statements in Part I, Item 2 of this Quarterly Report on Form 10-Q. Except as set forth below, there have been no material changes with respect to the risk factors disclosed in our 2019 Form 10-K. The risk factors set forth below update, and should be read together with, the risk factors in our 2019 Form 10-K. You should carefully consider such factors, which could materially affect our business, financial condition or future results. The risks described in this Quarterly Report on Form 10-Q and in the 2019 Form 10-K are not the only risks facing our company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our business, financial condition and/or operating results.

The extent to which the COVID-19 pandemic or any other potential future public health crises, pandemics or similar events will adversely impact our business, financial condition and results of operations is highly uncertain and cannot be predicted.

The COVID-19 pandemic has created significant worldwide uncertainty, volatility and economic disruption. The extent to which COVID-19 and any other potential future public health crises, pandemics or similar events will adversely impact our business, financial condition and results of operations is dependent upon numerous factors, many of which are highly uncertain, rapidly changing and uncontrollable. These factors include, but are not limited to: (i) the duration and scope of the pandemic or other event; (ii) governmental, business and individual actions that have been and continue to be taken in response to the pandemic or other event, including travel restrictions, quarantines, social distancing, work-from-home and shelter-in-place orders and shut-downs; (iii) the impact on our customers, including those that are presently unlicensed, and other business partners; (iv) the impact on U.S. and global economies and the timing and rate of economic recovery; (v) potential adverse effects on the financial markets and access to capital; (vi) potential goodwill or other impairment charges; (vii) increased cybersecurity risks as a result of pervasive remote working conditions; (viii) our ability to effectively carry out our operations due to any adverse impacts on the health and safety of our employees and their families; (ix) the ability of our customers to timely satisfy their payment obligations to us; and (x) fluctuations in global shipments of handsets and consumer electronics devices. Furthermore, as a result of the COVID-19 pandemic, our employees have been required to work from home and our office locations have remain closed. The significant increase in remote working, particularly for an extended period of time, could exacerbate certain risks to our business, including an increased risk of cybersecurity events, improper dissemination of personal or confidential information and breakdowns in internal controls and processes.

Any of the foregoing factors could amplify the other risks and uncertainties described in our 2019 Form 10-K and could materially adversely affect our business, financial condition, and results of operations. Because the COVID-19 pandemic is unprecedented and continuously evolving, the other potential impacts to our risk factors described in our 2019 Form 10-K are uncertain.

We may have exposure to additional tax liabilities.

The United States government enacted tax reform in 2017 and continues to provide regulatory guidance related to tax reform provisions, and state authorities continue to provide guidance around its application of tax reform provisions, that in each case could impact future effective tax rates favorably or unfavorably. The international tax environment also continues to change as a result of both coordinated efforts by governments and unilateral measures designed by individual countries, which could ultimately have an adverse effect on the taxation of international businesses such as ours. Accordingly, our tax rate could be adversely affected by several factors, many of which are outside of our control, including: changing tax laws, regulations and interpretations thereof; changes in tax rates; and assessments and any related tax, interest or penalties. If we are deemed to owe additional taxes, our business, financial condition, and results of operations could be adversely affected.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-07-01 to 2020-09-30$87.5mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2020-01-01 to 2020-09-30$268.2mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Research and development3 months2020-07-01 to 2020-09-30$20.8mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2020-01-01 to 2020-09-30$61.8mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2020-07-01 to 2020-09-30$10.9mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2020-01-01 to 2020-09-30$35.3mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2020-07-01 to 2020-09-30$15.4mus-gaap:OperatingIncomeLoss
Operating income9 months2020-01-01 to 2020-09-30$52.0mus-gaap:OperatingIncomeLoss
Interest expense3 months2020-07-01 to 2020-09-30$10.4mus-gaap:InterestExpense
Interest expense9 months2020-01-01 to 2020-09-30$30.9mus-gaap:InterestExpense
Income tax3 months2020-07-01 to 2020-09-30−$12.8mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2020-01-01 to 2020-09-30−$5.9mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2020-07-01 to 2020-09-30$23.8mus-gaap:NetIncomeLoss
Net income9 months2020-01-01 to 2020-09-30$46.2mus-gaap:NetIncomeLoss
Diluted EPS3 months2020-07-01 to 2020-09-30$0.76us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2020-01-01 to 2020-09-30$1.49us-gaap:EarningsPerShareDiluted
Basic EPS3 months2020-07-01 to 2020-09-30$0.77us-gaap:EarningsPerShareBasic
Basic EPS9 months2020-01-01 to 2020-09-30$1.50us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2020-07-01 to 2020-09-3031,119,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2020-01-01 to 2020-09-3031,029,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2020-01-01 to 2020-09-30$144.2mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2020-01-01 to 2020-09-30$9.9mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid9 months2020-01-01 to 2020-09-30$32.3mus-gaap:PaymentsOfDividends
Share repurchases9 months2020-01-01 to 2020-09-30$349.0kus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2020-09-30$746.6mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-09-30$1.03bnus-gaap:AssetsCurrent
Total assetsAt period end2020-09-30$1.64bnus-gaap:Assets
Current liabilitiesAt period end2020-09-30$317.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-09-30$837.8mus-gaap:Liabilities
Long-term debtAt period end2020-09-30$363.5mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2020-09-30$0us-gaap:LongTermDebtCurrent
Short-term borrowingsAt period end2020-09-30$51.4mus-gaap:CommercialPaper
Shareholders' equityAt period end2020-09-30$783.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001405495-20-000054. Last ingested by Listed: Nov 6, 2026, 12:17 ET. Listed shows no prices and gives no investment advice.